< 1 minute read
Dec. 16, 2021
TAK-071: a Brain-Penetrant M1R Positive Allosteric Modulator (PAM)
TAK-071
low α- M1R positive allosteric modulator 7.5 mg+ PO QD in Ph. II for Parkinson’s from eval. of M1R PAMs w/ low cooperativity British Journal of Clinical Pharmacology Takeda Pharmaceutical, Cambridge, USA
Loading...
